NeoGenomics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $21.5M | $13.9M | $7.5M | $5.4M |
| FY2017 | $18.0M | $4.3M | $13.7M | $6.4M |
| FY2018 | $44.8M | $30.5M | $14.3M | $7.0M |
| FY2019 | $23.4M | $3.3M | $20.0M | $10.0M |
| FY2020 | $1.5M | $-27.6M | $29.1M | $10.2M |
| FY2021 | $-26.7M | $-90.9M | $64.1M | $22.5M |
| FY2022 | $-66.0M | $-96.9M | $30.9M | $24.7M |
| FY2023 | $-2.0M | $-30.7M | $28.8M | $24.6M |
| FY2024 | $7.0M | $-34.0M | $41.1M | $33.4M |
| FY2025 | $5.2M | $-21.8M | $27.0M | $41.3M |